News FDA approves Valeant eye drug after manufacturing delay Regulator backs potential blockbuster ophthalmology drug
Views & Analysis Learning from a successful ophthalmology brand launch Applying learnings from a successful ophthalmology brand launch to other therapy areas and pharmaceutical brands.
Partner Content Partner Content SMi’s Ophthalmic Drugs Conference is only 4 weeks away! Only 4 Weeks Remain for Ophthalmic Drugs
Partner Content Partner Content Spotlight on Key Sessions at Ophthalmic Drugs this November Sessions at Ophthalmic Drugs
News Judge throws out Allergan patents, criticises Native America... Federal court throws out patents on Restasis
Partner Content Partner Content Exceptional speaker line-up for Ophthalmic Drugs Hear from Santen, Novaliq GmBh, Aptar Pharma and more
R&D The long-delayed promise of the microbiome, with Sam Possemi... Sam Possemiers, CEO of MRM Health, believes that the microbiome space is finally coming into maturity.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
